Deciphering clinical features and pathogenesis of myelin oligodendrocyte glycoprotein (MOG) antibodies in adult patients with a first demyelinating syndrome
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
